223 related articles for article (PubMed ID: 22704961)
1. T cells, murine chronic graft-versus-host disease and autoimmunity.
Eisenberg RA; Via CS
J Autoimmun; 2012 Sep; 39(3):240-7. PubMed ID: 22704961
[TBL] [Abstract][Full Text] [Related]
2. CTL-Promoting Effects of IL-21 Counteract Murine Lupus in the Parent→F1 Graft-versus-Host Disease Model.
Nguyen V; Rus H; Chen C; Rus V
J Immunol; 2016 Feb; 196(4):1529-40. PubMed ID: 26792801
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic Differences in Donor CD4 T Cell IL-2 Production Influence Severity of Parent-into-F1 Murine Lupus by Skewing the Immune Response Either toward Help for B Cells and a Sustained Autoantibody Response or toward Help for CD8 T Cells and a Downregulatory Th1 Response.
Soloviova K; Puliaiev M; Haas M; Dalgard CL; Schaefer BC; Via CS
J Immunol; 2015 Oct; 195(7):2985-3000. PubMed ID: 26320249
[TBL] [Abstract][Full Text] [Related]
4. T cell TRAIL promotes murine lupus by sustaining effector CD4 Th cell numbers and by inhibiting CD8 CTL activity.
Rus V; Nguyen V; Puliaev R; Puliaeva I; Zernetkina V; Luzina I; Papadimitriou JC; Via CS
J Immunol; 2007 Mar; 178(6):3962-72. PubMed ID: 17339497
[TBL] [Abstract][Full Text] [Related]
5. Donor CD8 T cells and IFN-gamma are critical for sex-based differences in donor CD4 T cell engraftment and lupus-like phenotype in short-term chronic graft-versus-host disease mice.
Foster AD; Soloviova K; Puliaeva I; Puliaiev M; Puliaev R; Finkelman F; Via CS
J Immunol; 2011 Jun; 186(11):6238-54. PubMed ID: 21531893
[TBL] [Abstract][Full Text] [Related]
6. Thymic damage, impaired negative selection, and development of chronic graft-versus-host disease caused by donor CD4+ and CD8+ T cells.
Wu T; Young JS; Johnston H; Ni X; Deng R; Racine J; Wang M; Wang A; Todorov I; Wang J; Zeng D
J Immunol; 2013 Jul; 191(1):488-99. PubMed ID: 23709681
[TBL] [Abstract][Full Text] [Related]
7. IL-21 promotes lupus-like disease in chronic graft-versus-host disease through both CD4 T cell- and B cell-intrinsic mechanisms.
Nguyen V; Luzina I; Rus H; Tegla C; Chen C; Rus V
J Immunol; 2012 Jul; 189(2):1081-93. PubMed ID: 22723520
[TBL] [Abstract][Full Text] [Related]
8. Donor CD8 T cell activation is critical for greater renal disease severity in female chronic graft-vs.-host mice and is associated with increased splenic ICOS(hi) host CD4 T cells and IL-21 expression.
Foster AD; Haas M; Puliaeva I; Soloviova K; Puliaev R; Via CS
Clin Immunol; 2010 Jul; 136(1):61-73. PubMed ID: 20451460
[TBL] [Abstract][Full Text] [Related]
9. The parent-into-F1 murine model in the study of lupus-like autoimmunity and CD8 cytotoxic T lymphocyte function.
Soloviova K; Puliaiev M; Foster A; Via CS
Methods Mol Biol; 2012; 900():253-70. PubMed ID: 22933073
[TBL] [Abstract][Full Text] [Related]
10. B cells require "nurturing" by CD4 T cells during development in order to respond in chronic graft-versus-host model of systemic lupus erythematosus.
Choudhury A; Cohen PL; Eisenberg RA
Clin Immunol; 2010 Jul; 136(1):105-15. PubMed ID: 20381429
[TBL] [Abstract][Full Text] [Related]
11. Alloimmune response results in expansion of autoreactive donor CD4+ T cells in transplants that can mediate chronic graft-versus-host disease.
Zhao D; Young JS; Chen YH; Shen E; Yi T; Todorov I; Chu PG; Forman SJ; Zeng D
J Immunol; 2011 Jan; 186(2):856-68. PubMed ID: 21149609
[TBL] [Abstract][Full Text] [Related]
12. Tissue-resident PSGL1loCD4+ T cells promote B cell differentiation and chronic graft-versus-host disease-associated autoimmunity.
Kong X; Zeng D; Wu X; Wang B; Yang S; Song Q; Zhu Y; Salas M; Qin H; Nasri U; Haas KM; Riggs AD; Nakamura R; Martin PJ; Huang A; Zeng D
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 32931481
[TBL] [Abstract][Full Text] [Related]
13. Both perforin and FasL are required for optimal CD8 T cell control of autoreactive B cells and autoantibody production in parent-into-F1 lupus mice.
Soloviova K; Puliaiev M; Puliaev R; Puliaeva I; Via CS
Clin Immunol; 2018 Sep; 194():34-42. PubMed ID: 29940333
[TBL] [Abstract][Full Text] [Related]
14. Maintenance of CD8+ T-cell anergy by CD4+CD25+ regulatory T cells in chronic graft-versus-host disease.
Kim J; Kim HJ; Choi WS; Nam SH; Cho HR; Kwon B
Exp Mol Med; 2006 Oct; 38(5):494-501. PubMed ID: 17079865
[TBL] [Abstract][Full Text] [Related]
15. Breaking of CD8+ T cell tolerance through in vivo ligation of CD40 results in inhibition of chronic graft-versus-host disease and complete donor cell engraftment.
Kim J; Park K; Kim HJ; Kim J; Kim HA; Jung D; Kim HJ; Choi HJ; Choi SY; Seo KW; Cho HR; Kwon B
J Immunol; 2008 Nov; 181(10):7380-9. PubMed ID: 18981161
[TBL] [Abstract][Full Text] [Related]
16. CTL-promoting effects of CD40 stimulation outweigh B cell-stimulatory effects resulting in B cell elimination and disease improvement in a murine model of lupus.
Puliaev R; Puliaeva I; Welniak LA; Ryan AE; Haas M; Murphy WJ; Via CS
J Immunol; 2008 Jul; 181(1):47-61. PubMed ID: 18566369
[TBL] [Abstract][Full Text] [Related]
17. Donor B cells in transplants augment clonal expansion and survival of pathogenic CD4+ T cells that mediate autoimmune-like chronic graft-versus-host disease.
Young JS; Wu T; Chen Y; Zhao D; Liu H; Yi T; Johnston H; Racine J; Li X; Wang A; Todorov I; Zeng D
J Immunol; 2012 Jul; 189(1):222-33. PubMed ID: 22649197
[TBL] [Abstract][Full Text] [Related]
18. Regulatory role of host CD8+ T lymphocytes in experimental graft-versus-host disease across a single major histocompatibility complex class II incompatibility.
de Lavareille A; Prigogine C; Paulart F; Nagy N; Habran C; Haddou NO; Le Moine A; Salmon I; Goldman M; Flamand V
Transplantation; 2005 Nov; 80(9):1293-9. PubMed ID: 16314798
[TBL] [Abstract][Full Text] [Related]
19. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules.
Kramar G; Schurmans S; Berney M; Izui S; del Giudice G; Lambert PH
J Autoimmun; 1995 Apr; 8(2):177-92. PubMed ID: 7612147
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic and Therapeutic Effects of Interleukin-2 (IL-2)/Anti-IL-2 Complexes in Systemic Lupus Erythematosus-Like Chronic Graft-Versus-Host Disease.
Heiler S; Lötscher J; Kreuzaler M; Rolink J; Rolink A
Front Immunol; 2018; 9():656. PubMed ID: 29670626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
